Sort by:
1–16 of 4630 Results
-
SaleLuradox 40 mgLuradox 40 mg is an atypical antipsychotic. This is used for the treatment of: Schizophrenia, Depressive episodes associated with Bipolar I Disorder (bipolar depression), as monotherapy and as adjunctive therapy with lithium or valproate.Theropeutic ClassAtypical neuroleptic drugsPharmacologyThe efficacy of Lurasidone in schizophrenia could be mediated through a combination of central Dopamine D2 and Serotonin 5HT2A receptor antagonism.Dosage & Administration of Luradox 40 mgSchizophrenia- Starting Dose: 40 mg once daily Recommended Dose:?40 mg to 160 mg once daily Bipolar Depression- Starting Dose:?20 mg once daily Recommended Dose:?20 mg to 120 mg once daily Lurasidone ?should be taken with food. Administration with food substantially increases the absorption of Lurasidone.Dosage of Luradox 40 mgSchizophrenia- Starting Dose: 40 mg once daily Recommended Dose:?40 mg to 160 mg once daily Bipolar Depression- Starting Dose:?20 mg once daily Recommended Dose:?20 mg to 120 mg once daily Lurasidone ?should be taken with food. Administration with food substantially increases the absorption of Lurasidone.Interaction of Luradox 40 mgThe Lurasidone dose should be reduced to half of the original level when used concomitantly with moderate inhibitors of CYP3A4 (e.g., Diltiazem, Atazanavir, Erythromycin, Fluconazole, Verapamil, etc.). If Lurasidone is used concomitantly with a moderate CYP3A4 inducer, it may be necessary to increase the Lurasidone dose. Grapefruit: Grapefruit and grapefruit juice should be avoided in patients taking Lurasidone, since these may inhibit CYP3A4 and alter Lurasidone concentrations.ContraindicationsHypersensitivity. Concurrent administration of strong CYP3A4 inhibitors (eg, Ketoconazole). Concurrent administration of strong CYP3A4 inducers (eg, Rifampin). Dementia-related psychosis.Side Effects of Luradox 40 mgSomnolence, akathisia, extrapyramidal symptoms, and nausea.Pregnancy & LactationPregnancy Category B. Lurasidone should be used during pregnancy only if the potential benefit justifies the potential risk to the fetus. Patient should be advised not to breast-feed an infant if they are taking Lurasidone.Precautions & WarningsCerebrovascular adverse reactions in elderly patients with dementia-related psychosis: Increased incidence of cerebrovascular adverse events (e.g., stroke, transient ischemic attack).Neuroleptic malignant syndrome: Manage with immediate discontinuation and close monitoring.Tardive dyskinesia: Discontinue if clinically appropriate.Metabolic changes: Atypical antipsychotic drugs have been associated with metabolic changes that may increase cardiovascular/cerebrovascular risk. These metabolic changes include hyperglycemia, dyslipidemia, and weight gain.Hyperglycemia and diabetes mellitus: Monitor patients for symptoms of hyperglycemia including polydipsia, polyuria, polyphagia, and weakness. Monitor glucose regularly in patients with diabetes or at risk for diabetes.Dyslipidemia: Undesirable alterations have been observed in patients treated with atypical antipsychotics.Weight Gain: Gain in body weight has been observed. Monitor weight.Hyperprolactinemia: Prolactin elevations may occur.Leukopenia, neutropenia and agranulocytosis:?Perform complete blood counts (CBC) in patients with a pre-existing low white blood cell count (WBC) or a history of leukopenia or neutropenia. Consider discontinuing Lurasidone if a clinically significant decline in WBC occurs in the absence of other causative factors.Orthostatic hypotension and syncope: Dizziness, tachycardia or bradycardia, and syncope may occur, especially early in treatment. In patients with known cardiovascularor cerebrovascular disease, and in antipsychotic-na?ve patients, consider a lower starting dose and slower titration.Storage ConditionsProtect from light and moisture, store below 30? C. Keep out of the reach of children.Use In Special PopulationsModerate and Severe Renal Impairment: Recommended starting dose is 20 mg per day, and the maximum recommended dose is 80 mg per day . Moderate and Severe Hepatic Impairment: Recommended starting dose is 20 mg per day. The maximum recommended dose is 80 mg per day in moderate hepatic impairment and 40 mg per day in severe hepatic impairment.Drug ClassesAtypical neuroleptic drugsMode Of ActionThe efficacy of Lurasidone in schizophrenia could be mediated through a combination of central Dopamine D2 and Serotonin 5HT2A receptor antagonism.PregnancyPregnancy Category B. Lurasidone should be used during pregnancy only if the potential benefit justifies the potential risk to the fetus. Patient should be advised not to breast-feed an infant if they are taking Lurasidone.Pediatric UsesModerate and Severe Renal Impairment: Recommended starting dose is 20 mg per day, and the maximum recommended dose is 80 mg per day . Moderate and Severe Hepatic Impairment: Recommended starting dose is 20 mg per day. The maximum recommended dose is 80 mg per day in moderate hepatic impairment and 40 mg per day in severe hepatic impairment.Sku: 1736095863-1062
Luradox40 mg
₦1,925.00Original price was: ₦1,925.00.₦1,732.50Current price is: ₦1,732.50.₦1,925.00Original price was: ₦1,925.00.₦1,732.50Current price is: ₦1,732.50. Add to basket Quick View -
SaleTocef 400 mgCefixime is an orally active cephalosporin antibiotic which has marked in-vitro bactericidal activity against a wide variety of Gram-positive and Gram-negative organism. Tocef 400 mg indicated for the treatment of the following acute infections when caused by susceptible microorganisms.Upper Respiratory Tract Infections (URTI): e.g. otitis media; and other URTI where the causative organism is known or suspected to be resistant to other commonly used antibiotics, or where treatment failure may carry significant risk. Lower Respiratory Tract Infections-e.g. bronchitis.Urinary Tract Infections:?e.g. cystitis, cystourethritis, pyelonephritis. Clinical efficacy has been demonstrated in infections caused by commonly occurring pathogens including Streptococcus pneumonia, Streptococcus pyogenes, Escherichia coli, Proteus mirabilis, Klebsiella species, Haemophilus influenzae (beta-lactamase positive and negative), Moraxella catarrhalis (beta-lactamase positive and negative) and Enterobacter species. Cefixime is highly stable in the presence of beta-lactamase enzymes.Theropeutic ClassThird generation CephalosporinsPharmacologyCefixime is a third generation semisynthetic cephalosporin antibiotic for oral administration. It is bactericidal against a broad spectrum of gram positive and gram negative bacteria at easily achievable plasma concentrations. It kills bacteria by interfering in the synthesis of bacterial cell wall. It is highly stable in the presence of Beta-lactamase enzyme. As a result, many organisms resistant to penicillins and some cephalsporins due to the presence of beta-lactamases, may be susceptible to Cefixime. Absorption of it is about 40% to 50% whether administered with or without food.Dosage & Administration of Tocef 400 mgThe usual course of treatment is 7 days. This may be continued for up to 14 days depending on the severity of the infection.Adult and children over 12 years: The recommended adult dose is 200-400 mg (1 to 2 capsules) daily, given either as a single dose or in two divided doses. For the treatment of uncomplicated cervical/urethral gonococcal infections, a single oral dose of Cefixime 400 mg is recommended.Children (6 month or older): Usually 8 mg/kg/day given as a single dose or in two divided doses or may be given as following ?-1 year: 75 mg daily. 1-4 years: 100 mg daily. 5-10 years: 200 mg daily. 11-12 years: 300 mg daily In typhoid fever, dosage should be 10 mg/kg/day for 14 days. Children (under 6 month): The safety and efficacy of Cefixime has not been established in children aged less than 6 months.Dosage of Tocef 400 mgAbsorption of Cefixime is not significantly modified by the presence of food. The usual course of treatment is 7 days. This may be continued for up to 14 days if required. Adults and children over 10 years: The recommended adult dosage is 200-400 mg daily according to the severity of the infection, given either as a single dose or in two divided doses. Elderly: Elderly patients may be given the same dose as recommended for adults. Renal function should be assessed and dosage should be adjusted in severe renal impairment. Children: The recommended dosage for children is 8 mg/kg/day administered as a single dose or in two divided doses. As a general guide for prescribing in children the following daily doses in terms of volume of suspension are suggested: 6 months up to 1 year: 3.75 ml daily Children 1-4 years: 5 ml daily Children 5-10 years: 10 ml daily In typhoid: the recommended children dose is 5 mg/kg body weight twice daily for 10-14 days. Children weighing more than 50 kg or older than 10 years: Should be treated with the recommended adult dose 200-400 mg daily depending on the severity of infection. Children aged less than 6 months: The safety and efficacy of Cefixime has not been established in children aged less than 6 months.Dosage in Renal Impairment: Cefixime may be administered in the presence of impaired renal function. Normal dose and schedule may be given in patients with creatinine clearances of 20 ml/min or greater. In patients whose creatinine clearance is less than 20 ml/min, it is recommended that a dose of 200 mg once daily should not be exceeded. The dose and regimen for patients who are maintained on chronic ambulatory peritoneal dialysis or haemodialysis should follow the same recommendation as that for patients with creatinine clearances of less than 20 ml/min.Interaction of Tocef 400 mgIn common with other cephalosporins, increases in prothrombin times have been noted in a few patients. Care should therefore be taken in patients receiving anticoagulant therapy.ContraindicationsPatients with known hypersensitivity to cephalosporin antibiotics.Side Effects of Tocef 400 mgCefixime is generally well tolerated. The majority of adverse reactions observed in clinical trials were mild and self limiting in nature. Gastrointestinal disturbances: The most frequent side-effects seen with Cefixime are diarrhoea and stool changes; diarrhoea has been more commonly associated with higher doses. Other gastrointestinal side-effects seen less frequently are nausea, abdominal pain, dyspepsia, vomiting and flatulence. Pseudomembraneous colitis has been reported. Central nervous system: headache and dizziness. Hypersensitivity reactions: allergies in the form of rash, pruritis, urticaria, drug fever and arthralgia have been observed. These reactions usually subsided upon discontinuation of therapy. Hematological and clinical chemistry: thrombocytopenia, leukopenia and eosinophilia have been reported. These reactions were infrequent and reversible. Mild transient change in liver and renal function tests have been observed. Miscellaneous: other possible reactions include genital pruritis and vaginitis.Pregnancy & LactationThere are, however, no adequate and well-controlled studies in pregnant women. Because animal reproduction studies are not always predictive of human response, this drug should be used during pregnancy only if clearly needed. It is not known that Cefixime is excreted in human milk. So, caution should be exercised when Cefixime is administered to a nursing woman.Precautions & WarningsCefixime should be given with caution to patients who have shown hypersensitivity to other drugs. Cephalosporin should be given with caution to penicillin-sensitive patients, as there is some evidence of partial cross-allergenicity between the penicillins and the cephalosporins. Patients have had severe reactions (including anaphylaxis) to both classes of drugs. If an allergic effect occurs with Cefixime, the drug should be discontinued and the patient treated with appropriate agents if necessary. Cefixime should be administered with caution in patients with markedly impaired renal function. Treatment with broad spectrum antibiotics alters the normal flora of the colon and may permit overgrowth of clostridia. Studies indicate that a toxin produced by Clostridium difficile is a primary cause of antibiotic-associated diarrhoea. Use in pregnancy and lactation: There are no adequate and well-controlled studies in pregnant women. Cefixime should therefore not be used in pregnancy or in nursing mothers unless considered essential by the physician.Overdose Effects of Tocef 400 mgGastric Lavage may be indicated; otherwise, no specific antidote exists. Cefixime is not removed in significant quantities from the circulation by hemodialysis or peritoneal dialysis. Adverse reactions in small numbers of healthy adult volunteers receiving single doses up to 2 g of Cefixime did not differ from the profile seen in patients treated at the recommended doses.Storage ConditionsKeep below 30?C temperature, protected from light & moisture. Keep out of the reach of children.Drug ClassesThird generation CephalosporinsMode Of ActionCefixime is a third generation semisynthetic cephalosporin antibiotic for oral administration. It is bactericidal against a broad spectrum of gram positive and gram negative bacteria at easily achievable plasma concentrations. It kills bacteria by interfering in the synthesis of bacterial cell wall. It is highly stable in the presence of Beta-lactamase enzyme. As a result, many organisms resistant to penicillins and some cephalsporins due to the presence of beta-lactamases, may be susceptible to Cefixime. Absorption of it is about 40% to 50% whether administered with or without food.PregnancyThere are, however, no adequate and well-controlled studies in pregnant women. Because animal reproduction studies are not always predictive of human response, this drug should be used during pregnancy only if clearly needed. It is not known that Cefixime is excreted in human milk. So, caution should be exercised when Cefixime is administered to a nursing woman.Sku: 1736095860-1061
Tocef400 mg
₦2,768.70Original price was: ₦2,768.70.₦2,492.05Current price is: ₦2,492.05.₦2,768.70Original price was: ₦2,768.70.₦2,492.05Current price is: ₦2,492.05. Add to basket Quick View -
SaleEcosprin 75 mgEcosprin 75 mg is indicated in the following indications - Prophylaxis against arterial occlusive events: Myocardial infarction, myocardial re-infarction, after bypass surgery, acute ischemic stroke/TIA. Mild to moderate pain: Headache, muscle pain, dysmenorrhea, and toothache, etc. Chronic disease accompanied by pain and inflammation: Osteoarthritis. Antipyretic: Cold fever and influenza.Theropeutic ClassAnti-platelet drugsPharmacologyBy decreasing platelet aggregation, Ecosprin 75 mg inhibits thrombus formation on the arterial side of circulation, where thrombi are formed by platelet aggregation and anticoagulants have little effect. It is the analgesic of choice for headache, transient musculoskeletal pain, and dysmenorrhea. It has anti-inflammatory and antipyretic properties, which may be useful. Enteric coating reduces the intestinal disturbance and gastrointestinal ulceration due to this medicine.Dosage & Administration of Ecosprin 75 mgPain, Inflammatory diseases and as Antipyretic: Ecosprin 75 mg 300 mg 1-3 tablets 6 hourly with a maximum daily dose of 4 g. Thrombotic cerebrovascular or Cardiovascular disease: Ecosprin 75 mg 300 mg 1 tablet or Ecosprin 75 mg 75 mg 4 tablets daily. After Myocardial infarction: Ecosprin 75 mg 75 mg 2 tablets daily for 1 month. Following By-pass surgery: Ecosprin 75 mg 75 mg 1 tablet daily.Interaction of Ecosprin 75 mgSalicylates may enhance the effect of anticoagulants, oral hypoglycemic agents, phenytoin, and sodium valproate. They inhibit the uricosuric effect of probenecid and may increase the toxicity of sulfonamides. They may also precipitate bronchospasm or induce attacks of asthma in susceptible subjects.ContraindicationsEcosprin 75 mg is contraindicated in children under 12 years of age (due to the risk of Reye's syndrome), during breastfeeding, and in cases of active peptic ulcer. It should also be avoided in conditions involving bleeding, such as hemophilia, intracranial hemorrhage, and other ulcerations.Side Effects of Ecosprin 75 mgSide effects for the typical dosage of Ecosprin 75 mg are generally mild and may include nausea, dyspepsia, gastrointestinal ulceration, and bronchospasm, among others.Precautions & WarningsIt should be administered cautiously in cases of asthma, uncontrolled blood pressure, and during pregnancy.It should be administered with caution to patients with nasal polyps and nasal allergies.Overdose Effects of Ecosprin 75 mgOverdosage can result in symptoms such as dizziness, tinnitus, sweating, nausea, vomiting, confusion, and hyperventilation. Severe overdosage may lead to central nervous system depression with coma, cardiovascular collapse, and respiratory depression. If an overdose is suspected, it is crucial to closely monitor the patient for at least 24 hours, as symptoms and salicylate blood levels may not become evident for several hours. The treatment for overdosage involves gastric lavage and forced alkaline diuresis. In severe cases, hemodialysis may be necessary.Storage ConditionsKeep all medicines out of reach of children. Store in a cool and dry place, protected from light.Drug ClassesAnti-platelet drugsMode Of ActionBy reducing platelet aggregation, Ecosprin 75 mg inhibits thrombus formation on the arterial side of circulation, where thrombi primarily form through platelet aggregation, and anticoagulants have limited impact. This medication is the preferred analgesic for addressing conditions such as headaches, transient musculoskeletal pain, and dysmenorrhea. It possesses anti-inflammatory and antipyretic properties, which can be beneficial. Enteric-coated Ecosprin 75 mg is effective in reducing intestinal disturbance and the risk of gastrointestinal ulceration due to its properties.PregnancyIt is particularly crucial to avoid using Ecosprin 75 mg during the final three months of pregnancy unless explicitly instructed by a physician, as it may lead to issues in the unborn child or complications during delivery. Ecosprin 75 mg can enter breast milk, so it should be administered cautiously to nursing mothers.Q: What is Ecosprin 75mg? Ecosprin 75mg is a low-dose aspirin tablet that is used to prevent blood clots. It works by blocking the action of an enzyme called cyclooxygenase, which is needed for platelets to clump together.? Q: What is Ecosprin 75mg used for? Ecosprin 75mg is used for several diseases, including Heart attack, Stroke, Blood clots in the legs (deep vein thrombosis), Blood clots in the lungs (pulmonary embolism), Recurrent chest pain (angina), and After a heart attack or stroke Q: How should I take Ecosprin 75mg? Ecosprin 75mg should be taken by mouth, with or just after food. It is important to take Ecosprin 75mg at the same time each day. Q: What are the side effects of Ecosprin 75mg? The most common side effects of Ecosprin 75mg are: Stomach upset, Heartburn, Drowsiness, Mild headache, Ankle swelling (oedema), Slow heart rate, and Nausea.? Q: Is Ecosprin 75mg safe to take? Ecosprin 75mg is generally safe to take, but it is important to talk to your doctor before taking it if you have any health conditions, such as: Bleeding disorders, Ulcers, Liver or kidney problems, and Allergies to aspirin or other nonsteroidal anti-inflammatory drugs (NSAIDs) Q: When will I feel better after taking the Ecosprin 75mg Tablet? It takes about 5 to 30 minutes for Ecosprin 75 Tablet to start working, but you may not feel any different until several weeks or months after you start taking it.Sku: 1736108153-4664
Ecosprin75 mg
₦440.00Original price was: ₦440.00.₦396.00Current price is: ₦396.00. -
SaleAtova 10 mgAtova 10 mg is indicated as an adjunct to diet to reduce elevated total cholesterol, LDL cholesterol, apolipoprotein B (Apo-B) and triglycerides levels in following diseases when response to diet and other non-pharmacological measures is inadequate. To reduce total cholesterol and LDL cholesterol in patients with heterozygous and homozygous familial hypercholesterolaemia. To reduce elevated cholesterol and triglycerides in patient with mixed dyslipidemia (Fredrickson Type Ia and Ib). For the treatment of patients with elevated serum triglyceride levels in hypertriglyceridaemia (Fredrickson Type IV). For the treatment of patients with dysbetalipoproteinaemia (Fredrickson Type III). To reduce cardiac ischaemic events in patients with asymptomatic or mild to moderate symptomatic coronary artery disease with elevated LDL-cholesterol level. To reduce total and LDL-cholesterol concentrations patients with hypercholesterolemia associated with or exacerbated by diabetes mellitus or renal transplantation.Theropeutic ClassOther Anti-anginal & Anti-ischaemic drugs, StatinsPharmacologyAtorvastatin is a selective inhibitor of HMG-CoA reductase. This enzyme is the rate-limiting enzyme responsible for the conversion of HMG-CoA to mevalonate, a precursor of sterols, including cholesterol. Atorvastatin lowers plasma cholesterol and lipoprotein levels by inhibiting HMG-CoA reductase and cholesterol synthesis in the liver and increases the number of hepatic LDL receptors on the cell surface for enhanced uptake and catabolism of LDL.Dosage & Administration of Atova 10 mgPrimary hypercholesterolaemia and combined hyperlipidaemia- Adults: Usually 10 mg once daily; if necessary, may be increased at intervals of at least 4 weeks to max. 80 mg once daily. Child (10-18 years): Initially 10 mg once daily, increased if necessary at intervals of at least 4 weeks to usual max. 20 mg once daily. Familial hypercholesterolaemia- Adults: Initially 10 mg daily, increased at intervals of at least 4 weeks to 40 mg once daily; if necessary, further increased to max. 80 mg once daily (or 40 mg once daily combined with anion-exchange resin in heterozygous familial hypercholesterolaemia). Child (10-18 years): Initially 10 mg once daily, increased if necessary at intervals of at least 4 weeks to usual max. 80 mg once daily. Prevention of cardiovascular events- Adults: Initially 10 mg once daily adjusted according to response.Dosage of Atova 10 mgPrimary hypercholesterolaemia and combined hyperlipidaemia- Adults: Usually 10 mg once daily; if necessary, may be increased at intervals of at least 4 weeks to max. 80 mg once daily. Child (10-18 years): Initially 10 mg once daily, increased if necessary at intervals of at least 4 weeks to usual max. 20 mg once daily. Familial hypercholesterolaemia- Adults: Initially 10 mg daily, increased at intervals of at least 4 weeks to 40 mg once daily; if necessary, further increased to max. 80 mg once daily (or 40 mg once daily combined with anion-exchange resin in heterozygous familial hypercholesterolaemia). Child (10-18 years): Initially 10 mg once daily, increased if necessary at intervals of at least 4 weeks to usual max. 80 mg once daily. Prevention of cardiovascular events- Adults: Initially 10 mg once daily adjusted according to response.Interaction of Atova 10 mgThe risk of myopathy during treatment with Atorvastatin is increased with concurrent administration of cyclosporin, fibric acid derivatives, erythromycin, azole antifungals and niacin. No clinically significant interactions were seen when Atorvastatin was administered with antihypertensives or hypoglycemic agents. Patients should be closely monitored if Atorvastatin is added to digoxin, erythromycin, oral contraceptives, colestipol, antacid and warfarin.ContraindicationsAtova 10 mg should not be used in patient with hypersensitivity to any component of this medication. It's contraindicated in active liver disease or unexplained persistent elevations of serum transaminases. It is also contraindicated in patient with history of serious adverse reaction to prior administration of HMG-CoA reductase inhibitors.Side Effects of Atova 10 mgAtova 10 mg is generally well-tolerated. The most frequent side effects related to Atova 10 mg are constipation, flatulence, dyspepsia, abdominal pain. Other side effects includes infection, headache, back pain, rash, asthenia, arthralgia, myalgia.Pregnancy & LactationAtova 10 mg is contraindicated in pregnancy and while breast-feeding. Women of child bearing potential should use appropriate contraceptive measures during Atorvastatin therapy. If the woman become pregnant while taking Atova 10 mg, it should be discontinued.Precautions & WarningsLiver effects: Liver function tests should be performed before the initiation of treatment and periodically thereafter. Atorvastatin should be used with caution in patients who consume substantial quantities of alcohol or have a history of liver disease. Atorvastatin therapy should be discontinued if markedly elevated CPK levels occur or myopathy is diagnosed or suspected.Overdose Effects of Atova 10 mgSpecific treatment is not available for atorvastatin overdose. The patient should be treated symptomatically and supportive measures instituted, as required. Liver function tests should be performed and serum CK levels should be monitored. Due to extensive atorvastatin binding to plasma proteins, hemodialysis is not expected to significantly enhance atorvastatin clearance.Storage ConditionsKeep in a dry place away from light and heat. Keep out of the reach of children.Use In Special PopulationsGeriatric Use: Of the 39,828 patients who received Atorvastatin in clinicalstudies, 15,813 (40%) were ?65 years old and 2,800 (7%) were ?75 years old. No overall differences in safety or effectiveness were observed between these subjects and younger subjects, and other reported clinicalexperience has not identified differences in responses between the elderly and younger patients, but greater sensitivity of some older adults cannot be ruled out. Since advanced age (?65 years) is a predisposing factor for myopathy, Atorvastatin?should be prescribed with caution in the elderly.Hepatic Impairment: Atorvastatin?is contraindicated in patients with active liver disease whichmay include unexplained persistent elevations in hepatic transaminase levelsDrug ClassesOther Anti-anginal & Anti-ischaemic drugs, StatinsMode Of ActionAtorvastatin is a selective inhibitor of HMG-CoA reductase. This enzyme is the rate-limiting enzyme responsible for the conversion of HMG-CoA to mevalonate, a precursor of sterols, including cholesterol. Atorvastatin lowers plasma cholesterol and lipoprotein levels by inhibiting HMG-CoA reductase and cholesterol synthesis in the liver and increases the number of hepatic LDL receptors on the cell surface for enhanced uptake and catabolism of LDL.PregnancyPregnancy: Atorvastatin is contraindicated during pregnancy. Safety in pregnant women has not been established. No controlled clinical trials with atorvastatin have been conducted in pregnant women. Rare reports of congenital anomalies following intrauterine exposure to HMG-CoA reductase inhibitors have been received. Animal studies have shown toxicity to reproduction. Maternal treatment with atorvastatin may reduce the fetal levels of mevalonate which is a precursor of cholesterol biosynthesis. Atorvastatin should not be used in women who are pregnant, trying to become pregnant or suspect they are pregnant. Treatment with atorvastatin should be suspended for the duration of pregnancy or until it has been determined that the woman is not pregnantLactation: It is not known whether atorvastatin or its metabolites are excreted in human milk. In rats, plasma concentrations of atorvastatin and its active metabolites are similar to those in milk. Because of the potential for serious adverse reactions, women taking atorvastatin should not breastfeed their infants. Atorvastatin is contraindicated during breastfeeding.Pediatric UsesHepatic impairment: Atova 10 mg should be used with caution in patients with hepatic impairment. Pediatric use: For patients aged 10 years and above, the recommended starting dose of atorvastatin is 10 mg per day with titration up to 20 mg per day. Atova 10 mg is not indicated in the treatment of patients below the age of 10 years.Q: What is Atova 10mg? Atova 10mg is a brand name for atorvastatin, used to lower cholesterol. People with high cholesterol or a high risk of heart disease can take the medicine. You can also take it for high triglycerides (fats) levels.? Q: How should I take Atova 10mg? Atova 10mg should be taken by mouth once daily, at the same time each day. It can be taken with or without food. Q: What are the side effects of Atova 10mg? Atova 10mg has some side-effects like nausea, weakness, muscle pain, stomach pain, etc. These side effects are mild and may subside by themselves.? Q: How long does it take for Atova 10mg to work? Atova 10mg usually starts to work within a few weeks of taking it. However, you may need to take it for 2 months to see the full benefits of the medication. Q: Can I stop taking Atova 10mg if I feel better? No, you should not stop taking Atova 10mg without talking to your doctor. Stopping suddenly can make your cholesterol levels go back up.Sku: 1736108150-4663
Atova10 mg
₦9,900.00Original price was: ₦9,900.00.₦8,910.00Current price is: ₦8,910.00.₦9,900.00Original price was: ₦9,900.00.₦8,910.00Current price is: ₦8,910.00. Add to basket Quick View -
SaleBizoran 5 mg+20 mgBizoran 5 mg+20 mg is indicated for the treatment of hypertension, alone or with other antihypertensive agents. This may also be used as initial therapy in patients who are likely to need multiple antihypertensive agents to achieve their blood pressure goals.Theropeutic ClassCombined antihypertensive preparationsPharmacologyAmlodipine is a dihydropyridine calcium channel blocker that inhibits the transmembrane influx of calcium ions into vascular smooth muscle & cardiac muscle. Amlodipine is a peripheral arterial vasodilator that acts directly on vascular smooth muscle to cause a reduction in peripheral vascular resistance & a reduction in blood pressure.Olmesartan is an angiotensin II receptor blocker that acts on AT1 subtype. By blocking the action of angiotensin II, Olmesartan dilates blood vessels and reduces blood pressure without affecting pulse rate.Dosage & Administration of Bizoran 5 mg+20 mgInitial Therapy: The usual starting dose of Bizoran 5 mg+20 mg is one tablet (5/20 mg) once daily. Thedosage can be increased after 1 to 2 weeks of therapy to a maximum dose is two tablets (10/40 mg) once daily as needed to control bloodpressure. This may be taken with or without food and may beadministered with other antihypertensive agents.Initial therapy with this combination product is not recommended in patients ?75 years old or with hepatic impairment. Replacement Therapy: Bizoran 5 mg+20 mg substituted for its individually titrated components. Whensubstituting for individual components, the dose of one or both of the components can be increased if blood pressure control has not been satisfactory. Add-on Therapy: Bizoran 5 mg+20 mg used to provide additional blood pressure lowering forpatients not adequately controlled with Amlodipine (or another dihydropyridinecalcium channel blocker) alone or with Olmesartan Medoxomil (or another angiotensin II receptor blocker) alone.Interaction of Bizoran 5 mg+20 mgThe pharmacokinetics of Amlodipine and Olmesartan Medoxomil are not altered when the drugs are co administered. No drug interaction studies have been conducted with Amlodipine and Olmesartan combination tablet and other drugs, although studies have been conducted with the individual Amlodipine and Olmesartan Medoxomil components and no significant drug interactions have been observed.ContraindicationsHypersensitivity to any of the component of this combination product.Side Effects of Bizoran 5 mg+20 mgThe reported adverse reactions were generally mild and seldom led to discontinuation of treatment. The most common side effects include edema, dizziness, flushing, palpitation. Other side effects may include vomiting, diarrhoea, rhabdomyolysis, alopecia, pruritus, urticaria etc.Pregnancy & LactationPregnancy: When pregnancy is detected, discontinue this combination product as soon as possible. When used in pregnancy during the second and third trimesters, drugs that act directly on the renin-angiotensin system can cause injury and even death to the developing fetus.Nursing Mothers: Because of the potential for adverse effects on the nursing infant, a decision should be made whether to discontinue nursing or discontinue the drug, taking into account the importance of the drug to the mother.Precautions & WarningsFetal/Neonatal Morbidity and Mortality: When pregnancy is detected, this combination should be discontinued as soon as possible.Hypotension in Volume or Salt Depleted Patients: Symptomatic hypotension may occur after initiation of treatment.Vasodilatation: Caution should be exercised when administering the drug, particularly in patients with severe aortic stenosis.Patients with Severe Obstructive Coronary Artery Disease: Patients may develop increased frequency, duration, or severity of angina or acute myocardial infarction on starting calcium channel blocker therapy or at the time of dosage increase.Patients with Congestive Heart Failure: Calcium channel blockers should be used with caution in patients with heart failure.Patients with Impaired Renal Function: Caution should be exercised when administering the drug to patients with renal impairment.Patients with Hepatic Impairment: Caution should be exercised when administering the drug to patients with severe hepatic impairment.Overdose Effects of Bizoran 5 mg+20 mgThere is no experience of overdose with Amlodipine & Olmesartan combination. The most likely effects of olmesartan medoxomil overdosage are hypotension and tachycardia; bradycardia could be encountered if parasympathetic (vagal) stimulation occurred.Amlodipine overdosage can be expected to lead to excessive peripheral vasodilatation with marked hypotension and possibly a reflex tachycardia. Marked and potentially prolonged systemic hypotension up to and including shock with fatal outcome has been reported.Storage ConditionsKeep out of the reach of children. Store below 30?C. Keep in the original package in a cool & dry place in order to protect from light and moisture.Use In Special PopulationsThe safety and effectiveness in pediatric patients have not been established.Q: What is Bizoran 5 mg+20 mg? Bizoran 5 mg+20 mg is a combination of two drugs: amlodipine and olmesartan. Amlodipine is a calcium channel blocker and olmesartan is an angiotensin receptor blocker (ARB). These two drugs work together to lower blood pressure. Q: What is Bizoran 5 mg+20 mg used for? Bizoran 5 mg+20 mg is recommended for treating high blood pressure (hypertension). You can also take it to reduce the risk of heart attack and stroke in people with high blood pressure. Q: How does Bizoran 5 mg+20 mg work? Amlodipine relaxes the muscles in the walls of blood vessels and makes blood flow more easily. On the other hand, Olmesartan blocks the effects of angiotensin II hormone, which makes blood vessels constrict. By blocking angiotensin II, olmesartan helps to relax blood vessels and lower blood pressure. Q: What are the side effects of Bizoran 5 mg+20 mg? Some common side effects of Bizoran 5 mg+20 mg are: Dizziness, Headache, Fatigue, Swelling in the hands or feet, Cough, Constipation Nausea, and Diarrhea.? Q: Can I take Bizoran 5 mg+20 mg if I am pregnant or breastfeeding? You should discuss with your doctor on the harms and benefits of Bizoran 5 mg+20 mg before taking it during pregnancy or breastfeeding.? Q: How should I take Bizoran 5 mg+20 mg? Bizoran 5 mg+20 mg is recommended to take with food to reduce the risk of stomach upset. Usually, you should take it once a day, but your doctor may prescribe it twice a day.Sku: 1736108147-4662
Bizoran5 mg+20 mg
₦9,904.95Original price was: ₦9,904.95.₦8,914.40Current price is: ₦8,914.40.₦9,904.95Original price was: ₦9,904.95.₦8,914.40Current price is: ₦8,914.40. Add to basket Quick View -
SaleThyrox 50 mcg As replacement therapy in hypothyroidism of any aetiology. Replacement therapy should not be instituted in transient hypothyroidism during the recovery phase of subacute Thyroiditis. For the suppression of Thyroid Stimulating Hormone (TSH) levels in the presence of goitres, nodules and after radiological and/or surgical treatment of Thyroid cancer. ... Read more As replacement therapy in hypothyroidism of any aetiology. Replacement therapy should not be instituted in transient hypothyroidism during the recovery phase of subacute Thyroiditis. For the suppression of Thyroid Stimulating Hormone (TSH) levels in the presence of goitres, nodules and after radiological and/or surgical treatment of Thyroid cancer. For the suppression of the goitrogenic effects of other drugs such as Lithium. As a diagnostic aid in suppression tests. Theropeutic ClassThyroid drugs & hormonePharmacologyThis tablet contains synthetic Levothyroxine (also called Thyroxine or T4) which is identical to the natural hormone T4, produced in the Thyroid gland. About 30% of T4 is converted to the much more active Triiodothyronine (T3) in peripheral tissues. TBG (Thyroxine Binding Globulin) is the major carrier of T4. This binding protects T4 from metabolism and excretion resulting in its long half-life in the circulation. Only about 0.03% of total T4 in plasma is unbound. The half-life of elimination of T4 is 6 to 7 days. In hyperthyroidism, the half-life is shortened to 3 or 4 days, whereas in hypothyroidism it may be 9 to 10 days. In conditions associated with reduced protein in plasma as in nephrosis or hepatic cirrhosis or when binding to protein is inhibited by certain drugs the half-life of T4 may be shortened. The liver is the major site of degradation of Thyroid hormones. T4 is conjugated with Glucuronic and Sulphate conjugates through the Phenolic hydroxyl group and excreted in the urine.There is an enterohepatic circulation of the Thyroid hormones, since they are liberated by hydrolysis in the intestine and reabsorbed. Because of the long half-life of T4, a steady blood level of the biologically more active T3 can be obtained from one single daily dose of Levothyroxine. Therefore, variations in the therapeutic effect are unlikely once the correct dosage has been established.Dosage & Administration of Thyrox 50 mcgAdult dose: Initial starting dose: 25-50 meg/day, with gradual increments in dose at 6-8 week intervals, as needed. The Thyrox 50 mcg dose is generally adjusted in 12.5-25 meg increments until the patient with primary hypothyroidism is clinically euthyroid and the serum TSH has normalized. In patients with severe hypothyroidism: Initial dose is 12.5-25 meg/day with increases of 25 meg/day every 2-4 weeks, accompanied by clinical and laboratory assessment,until the TSH level is normalized. In patients with secondary (pituitary) or tertiary (hypothalamic) hypothyroidism: Thyrox 50 mcg dose should be titrated until the patient is clinically euthyroid and the serum free - T4 level is restored to the upper half of the normal range. For patients older than 50 years or for patients under 50 years of age with underlying cardiac disease: 1.7 meg/kg/day. Pediatric Dosage Newborns: The recommended starting dose is 10-15 meg/kg/day. A lower starting dose should be considered in infants at risk for cardiac failure and the dose should be increased in 4-6 weeks as needed based on clinical and laboratory response to treatment. In infants with very low (12 years but growth and puberty incomplete: 2-3 meg/kg/day Growth and puberty complete: 1.7 meg/kg/day. The dose should be adjusted based on clinical response and laboratory parameters. In the treatment of goitres, nodules and Thyroid cancer, the objective is to ensure a constant and sufficient suppression of TSH. For suppression of TSH levels, a gradual increase in dosing is usually not necessary. For adults, the usual suppressive dosage of T4 is 2.6 meg/kg of body weight daily. When Thyrox 50 mcg is used as a diagnostic aid, the dosage depends on the type of investigation.Dosage of Thyrox 50 mcgAdult dose: Initial starting dose: 25-50 mcg/day, with gradual increments in dose at 6-8 week intervals, as needed. The Thyrox 50 mcg dose is generally adjusted in 12.5-25 mcg increments until the patient with primary hypothyroidism is clinically euthyroid and the serum TSH has normalized. In patients with severe hypothyroidism: Initial dose is 12.5-25 mcg/day with increases of 25 mcg/day every 2-4 weeks, accompanied by clinical and laboratory assessment,until the TSH level is normalized. In patients with secondary (pituitary) or tertiary (hypothalamic) hypothyroidism: Thyrox 50 mcg dose should be titrated until the patient is clinically euthyroid and the serum free - T4 level is restored to the upper half of the normal range. For patients older than 50 years or for patients under 50 years of age with underlying cardiac disease: 1.7 mcg/kg/day. Pediatric Dosage (Newborns): The recommended starting dose is 10-15 mcg/kg/day. A lower starting dose should be considered in infants at risk for cardiac failure and the dose should be increased in 4-6 weeks as needed based on clinical and laboratory response to treatment. In infants with very low (12 years but growth and puberty incomplete: 2-3 mcg/kg/day Growth and puberty complete: 1.7 mcg/kg/day. The dose should be adjusted based on clinical response and laboratory parameters.Interaction of Thyrox 50 mcgConcurrent use of tri/tetracyclic antidepressants and Levothyroxine may increase the therapeutic and toxic effects of both drugs, possibly due to increased receptor sensitivity to catecholamines.Toxic effects may include increased risk of cardiac arrhythmias and CNS stimulation; onset of action of tricyclics may be accelerated. Administration of sertraline in patients stabilized on Levothyroxine may result in increased Levothyroxine requirements. Addition of Levothyroxine to antidiabetic or insulin therapy may result in increased antidiabetic agent or insulin requirements. Careful monitoring of diabetic control is recommended, especially when thyroid therapy is started, changed, or discontinued. Serum digitalis glycoside levels may be reduced in hyperthyroidism or when the hypothyroid patient is converted to the euthyroid state. Therapeutic effect of digitalis glycosides may be reduced.Contraindications Untreated subclinical or overt Thyrotoxicosis of any etiology Acute Myocardial Infarction Uncorrected Adrenal failure. Side Effects of Thyrox 50 mcgAdverse reactions associated with Levothyroxine therapy are primarily those of hyperthyroidism due to therapeutic overdose. They include the following: General: Fatigue, increased appetite, weight loss, heat intolerance, fever, excessive sweating; Central nervous system: Headache, hyperactivity, nervousness, anxiety, irritability, emotional lability, insomnia. Musculoskeletal: Tremors, muscle weakness. Cardiovascular: Palpitations, tachycardia, arrhythmias, increased pulse and blood pressure Respiratory: Dyspnea. Gastrointestinal: Diarrhea, vomiting, abdominal cramps. Dermatologic: Hair loss, flushing. Pregnancy & LactationPregnancy Category A. Pregnancy may increase Levothyroxine requirements. Although Thyroid hormones are excreted only minimally in human milk,caution should be exercised when it is administered to a nursing woman.However, adequate replacement doses of Levothyroxine are generally needed to maintain normal lactation.Precautions & Warnings In patients whose hypothyroidism is due to a decrease in pituitary gland function, there may also be adrenocortical insufficiency;before starting Levothyroxine therapy, this should be treated by adequate replacement with Corticosteroids to prevent acute adrenal insufficiency. The choice of the starting dose and of any increases in dosing should be made with great care in patients with cardiovascular disease and/or severe and long-existing hypothyroidism.Too high an initial dose or too rapid an increase in dosing may lead to development or worsening of angina complaints, arrhythmias, myocardial infarction, cardiac failure or to sudden increase in blood pressure, especially in older patients. Any marked change of body weight during treatment with T4 requires adjustment of the dosage. When monitoring blood levels of T3 and T4, it should be borne in mind that a "high" normal to slightly increased T4 level will be necessary in order to obtain a normal level of T3. The correct dosage of Levothyroxine in primary hypothyroidism should generally be established by monitoring the serum level of TSH to see whether it has normalized. Because intoxication with Thyroid preparations may have serious consequences. Overdose Effects of Thyrox 50 mcgThe signs and symptoms of overdose are those of hyperthyroidism - agitation, confusion, irritability, hyperactivity, headache, sweating, mydriasis, tachycardia, arrhythmias, tachypnoea, pyrexia, increased bowel movements and convulsions. Cerebral embolism, shock, coma, and death have been reported. Symptoms may not necessarily be evident or may not appear until several days after ingestion of Thyrox 50 mcg. Dose of Thyrox 50 mcg should be reduced or temporarily discontinued if signs or symptoms of overdosage occur. Treatment is symptomatic.Storage ConditionsStore below 30?C and dry place, protect from light. Keep out of the reach of children.Drug ClassesThyroid drugs & hormoneMode Of ActionThis tablet contains synthetic Levothyroxine (also called Thyroxine or T4) which is identical to the natural hormone T4, produced in the Thyroid gland. About 30% of T4 is converted to the much more active Triiodothyronine (T3) in peripheral tissues. TBG (Thyroxine Binding Globulin) is the major carrier of T4. This binding protects T4 from metabolism and excretion resulting in its long half-life in the circulation. Only about 0.03% of total T4 in plasma is unbound. The half-life of elimination of T4 is 6 to 7 days. In hyperthyroidism, the half-life is shortened to 3 or 4 days, whereas in hypothyroidism it may be 9 to 10 days. In conditions associated with reduced protein in plasma as in nephrosis or hepatic cirrhosis or when binding to protein is inhibited by certain drugs the half-life of T4 may be shortened. The liver is the major site of degradation of Thyroid hormones. T4 is conjugated with Glucuronic and Sulphate conjugates through the Phenolic hydroxyl group and excreted in the urine.There is an enterohepatic circulation of the Thyroid hormones, since they are liberated by hydrolysis in the intestine and reabsorbed. Because of the long half-life of T4, a steady blood level of the biologically more active T3 can be obtained from one single daily dose of Levothyroxine. Therefore, variations in the therapeutic effect are unlikely once the correct dosage has been established.PregnancyPregnancy Category A. Pregnancy may increase Levothyroxine requirements. Although Thyroid hormones are excreted only minimally in human milk,caution should be exercised when it is administered to a nursing woman.However, adequate replacement doses of Levothyroxine are generally needed to maintain normal lactation.Q: What is Thyrox 50mcg used for? Thyrox 50mcg effectively treats hypothyroidism, a condition where the thyroid gland fails to produce enough thyroid hormone. Thyroid hormone is essential for many bodily functions, including metabolism, growth, and development. Q: How does Thyrox 50mcg work? Thyrox 50mcg is a synthetic form of thyroid hormone. It replaces the thyroid hormone that the body is failing to produce on its own. Q: What is the dosage of Thyrox 50mcg? The dosage of Thyrox 50mcg will vary depending on the individual's needs. It is important to start with a low dose and increase it gradually until the desired effect is achieved. Q: How long does it take for Thyrox 50mcg to work? It may take several weeks or even months to see the full effects of Thyrox 50mcg. However, most people will start to feel better within a few days or weeks of starting treatment. Q: What are the side effects of Thyrox 50mcg? The common side effects of Thyrox 50mcg are mild and go away on their own - Headache, Insomnia, Diarrhea, Tremors, Increased appetite, Sweating, and Weight loss. These serious issues are rare - Allergic reactions ,Heart problems, Liver problems, and Bone problems.? Q: What are the drug interactions of Thyrox 50mcg? Thyrox 50mcg can interact with a number of other medications. It is important to tell your doctor about all of the medications you are taking before starting Thyrox 50mcg.Sku: 1736108144-4661
Thyrox50 mcg
₦3,630.00Original price was: ₦3,630.00.₦3,267.00Current price is: ₦3,267.00.₦3,630.00Original price was: ₦3,630.00.₦3,267.00Current price is: ₦3,267.00. Add to basket Quick View -
SaleRosuva 10 mgRosuva 10 mg is indicated in- Heterozygous Hypercholesterolemia (Familial and Non familial) Homozygous Hypercholesterolemia (Familial) Mixed Dyslipidemia (Fredrickson Type IIa and IIb) Primary prevention of cardiovascular diseaseTheropeutic ClassOther Anti-anginal & Anti-ischaemic drugs, StatinsPharmacologyRosuva 10 mg is a selective and competitive inhibitor of HMG-CoA reductase, the rate-limiting enzyme that converts 3-hydroxy-3-methyl glutaryl coenzyme A to mevalonate, a precursor of cholesterol. It produces its lipid-modifying effects in two ways. First, it increases the number of hepatic LDL receptors on the cell surface to enhance uptake and catabolism of LDL. Second, the solution inhibits hepatic synthesis of VLDL, which reduces the total number of VLDL and LDL particles.Dosage of Rosuva 10 mgDose range: 5-40 mg once daily. Use 40 mg dose only for patients not reaching LDL-C goal with 20 mgHoFH: Starting dose 20 mg/day.Pediatric patients with HeFH: 5-10 mg/day for patients 8 to less than 10 years age, and 5-20 mg/day for patients 10 to 17 years of age.Pediatric patients with HoFH: 20 mg/day for patients 7 to 17 years of age.Administration of Rosuva 10 mgRosuva 10 mg can be taken with or without food, at any time of day.Interaction of Rosuva 10 mgRemarkable drug interactions of Rosuva 10 mg are: Cyclosporine: Combining these medications increases its exposure. The recommended dose should not exceed 5 mg once daily. Gemfibrosil: It is advisable to avoid combining these drugs. If necessary, limit the dosage to 10 mg once daily when used together. Lopinavir/Ritonavir or atazanavir/ritonavir: When used in combination, these medications can elevate its exposure. The recommended dose should be limited to 10 mg once daily. Coumarin anticoagulants: Combining with coumarin anticoagulants can prolong the international normalized ratio (INR). Achieve a stable INR before initiating treatment and monitor it frequently until it remains stable during therapy. Concomitant lipid-lowering therapies: When used with fibrates and niacin products, there may be an increased risk of skeletal muscle effects. ContraindicationsRosuva 10 mg is contraindicated if- Known hypersensitivity to product components Liver disease, which may include unexplained persistent elevations in hepatic transaminase levels Pregnant women and women who may become pregnant Nursing mothersSide Effects of Rosuva 10 mgRosuva 10 mg is generally well tolerated. The most frequent adverse events thought to be related to the medicine were headache, myalgia, constipation, asthenia, abdominal pain and nausea.Pregnancy & LactationThe safety in pregnant women has not been established. It is not known whether Rosuva 10 mg is excreted in human milk or not.Precautions & WarningsSkeletal muscle effects (e.g., myopathy and rhabdomyolysis): Risks increase with use of 40 mg dose, advanced age (>65 year), hypothyroidism, renal impairment and combination use with cyclosporine, lopinavir/ritonavir, atazanavir/ritonavir or certain other lipid-lowering drugs. Patients should be advised to promptly report unexplained muscle pain, tenderness or weakness. Rosuva 10 mg can be discontinued if signs or symptoms appear.Liver enzyme abnormalities and monitoring: Persistent elevations in hepatic transaminases can occur. Liver enzymes should be monitored before and during treatmentStorage ConditionsKeep below 30oC temperature, protected from light & moisture. Keep out of the reach of children.Use In Special PopulationsUse in children: The safety and effectiveness in pediatric patients have not been established.Sku: 1736108141-4660
Rosuva10 mg
₦12,100.00Original price was: ₦12,100.00.₦10,890.00Current price is: ₦10,890.00.₦12,100.00Original price was: ₦12,100.00.₦10,890.00Current price is: ₦10,890.00. Add to basket Quick View -
SaleBislol 2.5 mgBislol 2.5 mg is indicated in- Hypertension Angina Moderate to severe heart failureTheropeutic ClassAnti adrenergic agent (Beta blockers), Beta-adrenoceptor blocking drugs, Beta-blockersPharmacologyBisoprolol Hemifumarate is the most selective ?1 blocker. It displays highest level of affinity for the ?1 receptor than any other beta-blocker available up to now. Selectively blocks ?1 adrenergic receptor in the heart and vascular smooth muscle and reduces heart rate and cardiac output resulting in decrease of arterial hypertension. Lipid metabolism can be adversely affected by ?-blockers, in patients with non-?1 selective ?1-blocker, but Bisoprolol does not cause any change in the cholesterol fraction including the cardioprotective HDL-cholesterol, in long-term therapy.Dosage & Administration of Bislol 2.5 mgHypertension: The dose of Bisoprolol must be individualized to the needs of the patient. The usual starting dose is 5 mg once daily. In some patients, 2.5 mg may be an appropriate starting dose. If the antihypertensive effect of 5 mg is inadequate, the dose may be increased to 10 mg and then, if necessary, to 20 mg once daily. Angina: Usually 10 mg once daily (5 mg may be adequate in some patients) max 20 mg daily. Heart Failure: Initially 1.25 mg once daily (in the morning) for 1 week then, if well tolerated, increased to 2.5 mg once daily for 1 week, then 3.75 mg once daily for 1 week, then 5 mg once daily for 4 weeks, then- 7.5 mg once daily for 4 weeks, then 10 mg once daily maximum 10 mg daily.Interaction of Bislol 2.5 mgBisoprolol should not be combined with other ?-blocking agents.ContraindicationsIn patients with cardiogenic shock, overt heart failure, second or third degree A-V block, right ventricular failure secondary to pulmonary hypertension and sinus bradycardia.Side Effects of Bislol 2.5 mgGastro-intestinal disturbances, bradycardia, hypotension, headache, fatigue, sleep disturbances, dizziness, vertigo, thrombocytopenia, visual disturbances, alopecia may be occurred.Pregnancy & LactationThe safety of Bislol 2.5 mg during pregnancy has not been established.?No data is available for lactation.Precautions & WarningsMonitoring of renal, hepatic and hematopoietic function should be performed at regular intervals during long-term treatment with bisoprolol.Storage ConditionsKeep in a dry place away from light and heat. Keep out of the reach of children.Q: What is Bislol 2.5mg? Bislol 2.5mg is a beta-blocker medication. Beta-blockers work by blocking the effects of adrenaline, which makes your heart beat faster and your blood vessels narrower. The medication helps to lower blood pressure, reduce the workload on the heart, and prevent chest pain. Q: What is Bislol 2.5mg used for? Bislol 2.5mg is used to make your heart beat slower and your blood vessels wider. It's a medication for High blood pressure (hypertension), Chest pain (angina), and Heart failure.? Q: How should I take Bislol 2.5mg? You should take Bislol 2.5mg by mouth, with or without food, once daily. It's best practice to take the medicine at the same time each day.? Q: What are the side effects of Bislol 2.5mg? Bislol 2.5mg can have several side effects, including: Dizziness, Fatigue, Headache, Slow heart rate, Difficulty breathing, and Cold hands and feet.? Q: Is Bislol 2.5mg safe to take? Bislol 2.5mg is generally safe to take, but you should talk to your doctor before taking it if you have any health conditions, such as - Asthma, Diabetes, Heart problems, Liver or kidney problems, Low blood pressure, and Depression.Sku: 1736108138-4659
Bislol2.5 mg
₦5,390.00Original price was: ₦5,390.00.₦4,851.00Current price is: ₦4,851.00.₦5,390.00Original price was: ₦5,390.00.₦4,851.00Current price is: ₦4,851.00. Add to basket Quick View -
SaleUromax 0.4 mgUromax 0.4 mg is indicated for the treatment of the signs and symptoms of Benign Prostatic Hyperplasia (BPH).Theropeutic ClassBPH/ Urinary retention/ Urinary incontinencePharmacologyTamsulosin is an antagonist of ?1A-adrenoreceptors in the prostate. It binds selectively and competitively to postsynaptic ?1A-adrenoreceptors, which convey smooth muscle contraction, thereby relaxing prostatic and urethral smooth muscle.Dosage & Administration of Uromax 0.4 mgThe recommended dose of Tamsulosin?is 0.4 mg once daily. It should be administered approximately half/hour following the same meal each day. For those patients who fail to respond to the 0.4 mg dose after two to four weeks of dosing, the dose of Tamsulosin can be increased to 0.8mg once daily. If Tamsulosin administration is discontinued or interrupted for several days at either the 0.4 mg or 0.8 mg dose, therapy should be started again with the 0.4 mg once daily dose.Interaction of Uromax 0.4 mgIncreased plasma concentration with strong CYP3A4 inhibitors (e.g. ketoconazole). Moderate CYP3A4 inhibitors (e.g. erythromycin), strong (e.g. paroxetine) or moderate (e.g. terbinafine) CYP2D6 inhibitors may increase exposure of tamsulosin. Increased plasma concentration with cimetidine. Additive effect with other ?-adrenergic blocking agents. Concomitant use with PDE5 inhibitors may lead to symptomatic hypotension. Decreased plasma concentration with furosemide.ContraindicationsHistory of orthostatic hypotension. Severe hepatic impairment.Side Effects of Uromax 0.4 mgThe following adverse reactions have been reported during the use of Tamsulosin: dizziness, abnormal ejaculation, and less frequently (1-2%) headache, asthenia, postural hypotension, palpitations, and rhinitis.Gastrointestinal reactions such as nausea, vomiting, diarrhoea, and constipation can occasionally occur. Hypersensitivity reactions such as rash, pruritus, and urticaria can occur occasionally. As with other alpha-blockers, drowsiness, blurred vision, dry mouth, or edema can occur. Syncope has been reported rarely, and there have been very rare reports of angioedema and priapism.Pregnancy & LactationUromax 0.4 mg capsules are not indicated for use in women.Precautions & WarningsNot indicated for use in women. Severe renal impairment (CrCl <10 mL/min). Pregnancy and lactation.Overdose Effects of Uromax 0.4 mgAs overdose of Uromax 0.4 mg capsules lead to hypotension, support the cardiovascular system is of first importance. Restoration of blood pressure and normalization of heart rate may be accomplished by keeping the patient in supine position. If this measure is inadequate, then administration of intravenous fuid should be considered. Measures, such as emesis, can be taken to impede absorption. When large quantities are involved, gastric lavage can be applied and activated charcoal and an osmotic laxative, such as sodium sulphate, can be administered.Storage ConditionsStore between 20-25? C.Use In Special PopulationsUromax 0.4 mg capsules are not indicated for use in pediatric populations.Q: What is Uromax 0.4mg used for?? Uromax 0.4mg treats the symptoms of benign prostatic hyperplasia (BPH), also known as an enlarged prostate. BPH causes urination problems to older men, such as difficulty starting to urinate, weak urine flow, and the need to urinate frequently. Q: How does Uromax 0.4mg work?? Uromax 0.4mg relaxes the muscles in the prostate and bladder neck. Thus, ?urine flows easier through the urethra, the tube that carries urine from the bladder to the outside of the body. Q: What is the dosage of Uromax 0.4mg?? The usual dosage of Uromax 0.4mg is one capsule once daily. You can take it with or without food. However, the exact dosage can vary depending on the patient's individual response. Q: How long does it take for Uromax 0.4mg to work?? Uromax 0.4mg typically starts working within 1-2 hours of taking it. However, it may take up to 4 weeks to see the full effects of the medication. Q: What are the side effects of Uromax 0.4mg?? The most common side effects of Uromax 0.4mg are mild and go away on their own. They include - Dizziness, Headache, Runny nose, Ejaculatory disorders, and Retrograde ejaculation.? It also has some serious side effects but is rare. These side effects include: Allergic reactions, Priapism (a prolonged and painful erection), and Hypotension (low blood pressure).? Q: What are the drug interactions of Uromax 0.4mg?? Uromax 0.4mg interacts with a number of other medications. It is important to tell your doctor about all of the medications you are taking before starting Uromax 0.4mg. Q: Is Uromax 0.4mg safe to take during pregnancy or breastfeeding? Uromax 0.4mg is not recommended for use during pregnancy or breastfeeding. The medicine is indicated for use in men and not indicated for use in women, especially during pregnancy and breastfeeding.Sku: 1736108135-4658
Uromax0.4 mg
₦3,300.00Original price was: ₦3,300.00.₦2,970.00Current price is: ₦2,970.00.₦3,300.00Original price was: ₦3,300.00.₦2,970.00Current price is: ₦2,970.00. Add to basket Quick View -
SaleOsartil 50 mgHypertension: It is recommended to use Osartil 50 mg to treat hypertension. It could be used with other antihypertensive medications or taken alone (eg. thiazide diuretics). Renal Protection in Type-2 Diabetic Patients with Proteinuria: In hypertensive type-2 diabetics with proteinuria, which is defined as urine albumin to creatinine ratio >300 mg/g, Osartil 50 mg is advised to postpone the advancement of renal disease.Theropeutic ClassAngiotensin-ll receptor blockerPharmacologyThe first angiotensin II receptor blocker that is orally active without a peptide is Osartil 50 mg. It binds to the AT1 receptor, which is present in numerous tissues (such as the heart, kidneys, adrenal glands, and vascular smooth muscle), and inhibits several critical biological processes, such as vasoconstriction and the production of the hormone aldosterone that causes hypertension.Dosage & Administration of Osartil 50 mgFor the majority of patients, the beginning and maintenance dose is 50 mg once daily. Prior to raising the dose, 25 mg twice daily is advised if the antihypertensive impact of 50 mg once daily is insufficient. A starting dose of 25 mg once daily should be taken into consideration for individuals with intravascular volume depletion (such as those on high-dose diuretics). One or two doses of Osartil 50 mg can be given each day. From 25 mg to 100 mg is the range for the total daily dose.Dosage of Osartil 50 mgFor the majority of patients, the beginning and maintenance dose is 50 mg once daily. Prior to raising the dose, 25 mg twice daily is advised if the antihypertensive impact of 50 mg once daily is insufficient. A starting dose of 25 mg once daily should be taken into consideration for individuals with intravascular volume depletion (such as those on high-dose diuretics). One or two doses of Osartil 50 mg can be given each day. From 25 mg to 100 mg is the range for the total daily dose.Interaction of Osartil 50 mgLevels of the Osartil 50 mg active metabolite are decreased by rifampicin and fluconazole. The antihypertensive effects of hydrochlorothiazide and Osartil 50 mg used together may be potentiated. Increases in serum potassium may result from the concurrent use of potassium-sparing diuretics (such as spironolactone, triamterene, and amiloride), potassium supplements, or salt substitutes containing potassium. The non-steroidal anti-inflammatory medicine indomethacin may lessen the antihypertensive effects of losartan. The risk of renal impairment is increased by the concurrent use of an ACE inhibitor, an angiotensin receptor antagonist, an anti-inflammatory medication, and a thiazide diuretic.ContraindicationsPregnant women and individuals who are hypersensitive to any ingredient in this medication should not use Osartil 50 mg. Those with diabetes shouldn't take Aliskiren and Osartil 50 mg together.Side Effects of Osartil 50 mgOsartil 50 mg side effects are minor and short-lived in nature. Dizziness, diarrhea, nasal congestion, coughing, and upper respiratory infections are the most frequent adverse effects. Fatigue, oedema, chest pain, nausea, headaches, and pharyngitis are other adverse effects.Pregnancy & LactationCategory D for pregnancies. If Osartil 50 mg is given during the second or third trimester of pregnancy, the risk to the fetus increases. Given that numerous medicines are excreted in human milk and that it is unknown whether Osartil 50 mg is one of them, a choice should be taken regarding whether to stop breastfeeding or stop taking the medication, taking into account the significance of the medication to the mother.Precautions & WarningsIn addition to increasing fetal and neonatal morbidity and mortality, the use of Osartil 50 mg throughout the second and third trimesters of pregnancy decreases fetal renal function. Symptomatic hypotension may happen in people who are intravascularly volume-depleted (such as those taking high-dose diuretics). Patients with cirrhosis have a considerably higher plasma concentration of Osartil 50 mg. Patients with renal impairment have experienced changes in renal function, including renal failure.Storage ConditionsKeep dry and away from heat and light. Keep out of children's reach.Drug ClassesAngiotensin-ll receptor blockerMode Of ActionThe first angiotensin II receptor blocker that is orally active without a peptide is Osartil 50 mg. It binds to the AT1 receptor, which is present in numerous tissues (such as the heart, kidneys, adrenal glands, and vascular smooth muscle), and inhibits several critical biological processes, such as vasoconstriction and the production of the hormone aldosterone that causes hypertension.PregnancyCategory D for pregnancies. If Osartil 50 mg is given during the second or third trimester of pregnancy, the risk to the fetus increases. Given that numerous medicines are excreted in human milk and that it is unknown whether Osartil 50 mg is one of them, a choice should be taken regarding whether to stop breastfeeding or stop taking the medication, taking into account the significance of the medication to the mother.Q: What is Osartil 50mg? Osartil 50mg is a combination of two medicines - olmesartan medoxomil and amlodipine besylate. Olmesartan medoxomil is an angiotensin receptor blocker (ARB) to relax the blood vessels. Amlodipine besylate is a calcium channel blocker also for relaxing the blood vessels. Osartil 50mg is used to treat high blood pressure. Q: What are the benefits of taking Osartil 50mg? Osartil 50mg offers several benefits, including Lowers blood pressure, Reduces the risk of heart attack, stroke, and other cardiovascular problems, Improves blood flow to the heart and brain, and help to prevent kidney disease. Q: Who should not take Osartil 50mg? People with the following issues shouldn?t take Osartil 50mg -? Allergic reaction to olmesartan medoxomil and amlodipine besylate.? Kidney problems.? Liver problems.? Low blood pressure.? People who are pregnant or breastfeeding.? Q: What are the side effects of Osartil 50mg? The most common side effects of Osartil are - Dizziness, headache, fatigue, swelling of the hands and feet, cough, and rash.? Q: How should I take Osartil 50mg Osartil 50mg should be taken by mouth with or without food, as directed by your doctor. The usual dose is one tablet per day. However, the dosage may vary depending on your individual needs. Talk to your doctor about the best dosage for you. Q: What are the precautions for taking Osartil 50mg? Here are some precautions of taking Osartil 50mg -? Tell your doctor about all other medicines that you are taking, including over-the-counter medicines and herbal supplements. Do not stop taking Osartil 50mg without talking to your doctor. Be careful if you are driving or operating machinery, as Osartil 50mg may cause dizziness. If you have any side effects that are bothersome or do not go away, talk to your doctor.Sku: 1736108132-4657
Osartil50 mg
₦5,500.00Original price was: ₦5,500.00.₦4,950.00Current price is: ₦4,950.00.₦5,500.00Original price was: ₦5,500.00.₦4,950.00Current price is: ₦4,950.00. Add to basket Quick View -
SaleLinaglip 5 mgLinaglip 5 mg is prescribed to treat type 2 diabetes mellitus in adults to enhance glycaemic control. As monotherapy: in patients who cannot be properly managed by diet and exercise alone and for whom metformin is contraindicated owing to renal impairment or inappropriate due to intolerance. As monotherapy: in patients who cannot be properly managed by diet and exercise alone and for whom metformin is contraindicated owing to renal impairment or inappropriate due to intolerance. When diet and exercise plus metformin alone are insufficient to achieve adequate glycaemic control, combination therapy may be used. Examples include using sulphonylurea in addition to metformin when diet and exercise plus dual therapy with these drugs is insufficient to achieve adequate glycaemic control.Theropeutic ClassDipeptidyl Peptidase-4 (DPP-4) inhibitorPharmacologyLinaglip 5 mg is recommended for those with type 2 diabetes mellitus to help with glycemic management. The incretin hormones GLP-1 (glucagon-like peptide-4) and GIP are degraded by the enzyme DPP-4, which is inhibited by it (glucose-dependent insulinotropic polypeptide). By boosting the release of insulin from pancreatic beta () cells in a glucose-dependent manner and inhibiting the release of glucagon from pancreatic alpha () cells into the blood, this raises the concentrations of active incretin hormones.Dosage & Administration of Linaglip 5 mgYou should take Linaglip 5 mg once a day. When given along with metformin, you should keep it constant. A lower dose of sulfonylurea may be used in conjunction with another medication to lessen the risk of hypoglycemia. Individuals with renal impairment: No dose modification is necessary. It may be taken at any time of the day with or without food.Dosage of Linaglip 5 mgYou should take Linaglip 5 mg once a day. When given along with metformin, you should keep it constant. A lower dose of sulfonylurea may be used in conjunction with another medication to lessen the risk of hypoglycemia. Individuals with renal impairment: No dose modification is necessary. It may be taken at any time of the day with or without food.Interaction of Linaglip 5 mgThis medication does not inhibit other CYP isozymes but is a weak competitive and weak to moderate mechanism-based inhibitor of the CYP isozyme CYP3A4. It is unlikely that other medications will interact clinically meaningfully with Linaglip 5 mg, and clinical investigations have shown that the drug has no clinically significant impact on the pharmacokinetics of metformin, glyburide, simvastatin, warfarin, digoxin, or oral contraceptives.ContraindicationsHypersensitivity to any excipient or active ingredient.Side Effects of Linaglip 5 mgAlong with metformin and sulfonylurea, there is a chance of hypoglycemia, nasopharyngitis, cough, and pancreatitis.Pregnancy & LactationB-category pregnancy. Pregnant women have not been the subject of sufficient, rigorous investigations. As a result, only use this pills during pregnancy if absolutely necessary. It may or may not enter breast milk; this is unknown.Precautions & WarningsHypersensitivity to any excipient or active ingredient.Storage ConditionsKeep dry and away from heat and light. Keep out of children's reach.Drug ClassesDipeptidyl Peptidase-4 (DPP-4) inhibitorMode Of ActionLinaglip 5 mg is recommended for those with type 2 diabetes mellitus to help with glycemic management. The incretin hormones GLP-1 (glucagon-like peptide-1) and GIP are degraded by the enzyme DPP-4, which is inhibited by it (glucose-dependent insulinotropic polypeptide). By boosting the release of insulin from pancreatic beta () cells in a glucose-dependent manner and inhibiting the release of glucagon from pancreatic alpha () cells into the blood, Linaglip 5 mg raises the concentrations of active incretin hormones.PregnancyB-category pregnancy. Pregnant women have not been the subject of sufficient, rigorous investigations. As a result, only use Linaglip 5 mg pills during pregnancy if absolutely necessary. This medication may or may not enter breast milk; this is unknown.Sku: 1736108129-4656
Linaglip5 mg
₦12,100.00Original price was: ₦12,100.00.₦11,011.00Current price is: ₦11,011.00.₦12,100.00Original price was: ₦12,100.00.₦11,011.00Current price is: ₦11,011.00. Add to basket Quick View -
SaleClopid 75 mgAcute Coronary Syndrome (ACS):?Clopid 75 mg is indicated to reduce the rate of myocardial infarction (MI) and stroke in patients with non-ST-segment elevation ACS [unstable angina (UA)/non-ST-elevation myocardial infarction (NSTEMI)]. Recent MI, recent Stroke, or established Peripheral Arterial Disease: In patients with established peripheral arterial disease or with a history of recent myocardial infarction (MI) or recent stroke it is indicated to reduce the rate of MI and stroke.Theropeutic ClassAnti-platelet drugsPharmacologyClopidogrel is a prodrug. It inhibits platelet activation and aggregation through the irreversible binding of its active metabolite to the P2Y12 class of ADP receptors on platelets. Dose-dependent inhibition of platelet aggregation can be seen 2 hours after single oral doses. Repeated doses of 75 mg per day inhibit ADP-induced platelet aggregation on the first day, and inhibition reaches steady state between Day 3 and Day 7.Dosage & Administration of Clopid 75 mgAcute Coronary Syndrome: In patients who need an antiplatelet effect within hours, initiate clopidogrel with a single 300 mg (4 tablets) oral loading dose and then continue at 75 mg once daily. Initiating it without a loading dose will delay establishment of an antiplatelet effect by several days. Recent MI, Recent Stroke, or Established Peripheral Arterial Disease: 75 mg once daily orally without a loading dose.It is given orally with or without food.Dosage of Clopid 75 mgAcute Coronary Syndrome: In patients who need an antiplatelet effect within hours, initiate clopidogrel with a single 300 mg (4 tablets) oral loading dose and then continue at 75 mg once daily. Initiating it without a loading dose will delay establishment of an antiplatelet effect by several days. Recent MI, Recent Stroke, or Established Peripheral Arterial Disease: 75 mg once daily orally without a loading dose.It is given orally with or without food.Interaction of Clopid 75 mgNSAIDs, warfarin, selective serotonin and serotonin norepinephrine reuptake inhibitors (SSRIs, SNRIs): Increases risk of bleeding CYP2C19 inhibitors (omeprazole or esomeprazole): Avoid concomitant use of omeprazole or esomeprazole Repaglinide (CYP2C8 substrates): Avoid concomitant use of Clopidogrel with Repaglinide as it increases plasma concentrations of RepaglinideContraindicationsClopidogrel is contraindicated in the following conditions: Hypersensitivity to the drug substance or any component of the product. Active pathological bleeding such as peptic ulcer or intracranial hemorrhage.Side Effects of Clopid 75 mgClopidogrel is generally well tolerated drug. Common side effects: Bleeding, Diarrhoea, gastrointestinal discomfort, haemorrhage, Skin reactions. Rare side effects: Acquired haemophilia, anaemia, angioedema, arthralgia, arthritis, bone marrow disorders.Pregnancy & LactationThere are no adequate and well-controlled studies in pregnant women. Clopid 75 mg should be used during pregnancy only if clearly needed. It is unknown whether clopidogrel is excreted in human breast milk. A decision should be made whether to discontinue nursing or to discontinue the drug, taking into account the importance of the drug to the mother.Precautions & WarningsAs Clopid 75 mg is a prodrug, so metabolism to its active metabolite is impaired by genetic variations in CYP2C19 (poor metabolizer) and by the drugs that inhibit CYP2C19 such as Omeprazole and Esomeprazole. Concomitant use with these drugs and in CYP2C19 poor metaboliser may reduce the antiplatelet activity of Clopidogrel. As it inhibits platelet aggregation for the lifetime of the platelet (7-10 days), risk of bleeding may increase. To restore hemostasis, platelet transfusions within 4 hours of the loading dose or 2 hours of the maintenance dose may be less effective. Discontinuation of Clopidogrel increases the risk of cardiovascular events. Discontinue 5 days prior to elective surgery that has a major risk of bleeding. Resume Clopidogrel as soon as hemostasis is achieved. Thrombotic Thrombocytopenic Purpura (TTP) has been reported that requires urgent treatment including plasmapheresis (plasma exchange). Hypersensitivity including rash, angioedema or hematologic reaction has been reported in patients receiving clopidogrel or history of hypersensitivity to other thienopyridines.Overdose Effects of Clopid 75 mgOverdose following clopidogrel administration may lead to bleeding complications. Based on biological plausibility, platelet transfusion may restore clotting ability.Storage Conditions Keep below 30?C temperature in a dry place. Protected from light. Do not freeze. Keep out of the reach of children. Use In Special PopulationsSafety and effectiveness in pediatric populations have not been established. No dosage adjustment is necessary in elderly patients.Drug ClassesAnti-platelet drugsMode Of ActionClopidogrel is a prodrug. It inhibits platelet activation and aggregation through the irreversible binding of its active metabolite to the P2Y12 class of ADP receptors on platelets. Dose-dependent inhibition of platelet aggregation can be seen 2 hours after single oral doses. Repeated doses of 75 mg per day inhibit ADP-induced platelet aggregation on the first day, and inhibition reaches steady state between Day 3 and Day 7.PregnancyThere are no adequate and well-controlled studies in pregnant women. Clopid 75 mg should be used during pregnancy only if clearly needed. It is unknown whether clopidogrel is excreted in human breast milk. A decision should be made whether to discontinue nursing or to discontinue the drug, taking into account the importance of the drug to the mother.Pediatric UsesSafety and effectiveness in pediatric populations have not been established. No dosage adjustment is necessary in elderly patients.ABCSku: 1736108126-4655
Clopid75 mg
₦9,240.00Original price was: ₦9,240.00.₦8,316.00Current price is: ₦8,316.00.₦9,240.00Original price was: ₦9,240.00.₦8,316.00Current price is: ₦8,316.00. Add to basket Quick View -
SaleRosuva 5 mgRosuva 5 mg is indicated in- Heterozygous Hypercholesterolemia (Familial and Non familial) Homozygous Hypercholesterolemia (Familial) Mixed Dyslipidemia (Fredrickson Type IIa and IIb) Primary prevention of cardiovascular diseaseTheropeutic ClassOther Anti-anginal & Anti-ischaemic drugs, StatinsPharmacologyRosuva 5 mg is a selective and competitive inhibitor of HMG-CoA reductase, the rate-limiting enzyme that converts 3-hydroxy-3-methyl glutaryl coenzyme A to mevalonate, a precursor of cholesterol. It produces its lipid-modifying effects in two ways. First, it increases the number of hepatic LDL receptors on the cell surface to enhance uptake and catabolism of LDL. Second, the solution inhibits hepatic synthesis of VLDL, which reduces the total number of VLDL and LDL particles.Dosage of Rosuva 5 mgDose range: 5-40 mg once daily. Use 40 mg dose only for patients not reaching LDL-C goal with 20 mgHoFH: Starting dose 20 mg/day.Pediatric patients with HeFH: 5-10 mg/day for patients 8 to less than 10 years age, and 5-20 mg/day for patients 10 to 17 years of age.Pediatric patients with HoFH: 20 mg/day for patients 7 to 17 years of age.Administration of Rosuva 5 mgRosuva 5 mg can be taken with or without food, at any time of day.Interaction of Rosuva 5 mgRemarkable drug interactions of Rosuva 5 mg are: Cyclosporine: Combining these medications increases its exposure. The recommended dose should not exceed 5 mg once daily. Gemfibrosil: It is advisable to avoid combining these drugs. If necessary, limit the dosage to 10 mg once daily when used together. Lopinavir/Ritonavir or atazanavir/ritonavir: When used in combination, these medications can elevate its exposure. The recommended dose should be limited to 10 mg once daily. Coumarin anticoagulants: Combining with coumarin anticoagulants can prolong the international normalized ratio (INR). Achieve a stable INR before initiating treatment and monitor it frequently until it remains stable during therapy. Concomitant lipid-lowering therapies: When used with fibrates and niacin products, there may be an increased risk of skeletal muscle effects. ContraindicationsRosuva 5 mg is contraindicated if- Known hypersensitivity to product components Liver disease, which may include unexplained persistent elevations in hepatic transaminase levels Pregnant women and women who may become pregnant Nursing mothersSide Effects of Rosuva 5 mgRosuva 5 mg is generally well tolerated. The most frequent adverse events thought to be related to the medicine were headache, myalgia, constipation, asthenia, abdominal pain and nausea.Pregnancy & LactationThe safety in pregnant women has not been established. It is not known whether Rosuva 5 mg is excreted in human milk or not.Precautions & WarningsSkeletal muscle effects (e.g., myopathy and rhabdomyolysis): Risks increase with use of 40 mg dose, advanced age (>65 year), hypothyroidism, renal impairment and combination use with cyclosporine, lopinavir/ritonavir, atazanavir/ritonavir or certain other lipid-lowering drugs. Patients should be advised to promptly report unexplained muscle pain, tenderness or weakness. Rosuva 5 mg can be discontinued if signs or symptoms appear.Liver enzyme abnormalities and monitoring: Persistent elevations in hepatic transaminases can occur. Liver enzymes should be monitored before and during treatmentStorage ConditionsKeep below 30oC temperature, protected from light & moisture. Keep out of the reach of children.Use In Special PopulationsUse in children: The safety and effectiveness in pediatric patients have not been established.Sku: 1736108120-4654
Rosuva5 mg
₦6,600.00Original price was: ₦6,600.00.₦5,940.00Current price is: ₦5,940.00.₦6,600.00Original price was: ₦6,600.00.₦5,940.00Current price is: ₦5,940.00. Add to basket Quick View -
SaleRivotril 0.5 mgRivotril 0.5 mg serves as a treatment for panic disorder, whether with or without agoraphobia. Panic disorder manifests through unexpected panic attacks and the accompanying worry about experiencing more of these episodes, along with concerns about their implications or consequences.? Additionally, it is indicated for use on its own or as an adjunct in treating Lennox-Gastaut Syndrome (specifically the petit mal variant), akinetic seizures, and myoclonic seizures. It may also be considered for patients with absence seizures (petit mal) who have not responded to succinimides. It's important to note that the long-term effectiveness of the medicine, specifically for durations exceeding 9 weeks, hasn't been comprehensively studied in controlled clinical trials. Therefore, physicians who choose to prescribe Rivotril 0.5 mg for extended periods should periodically reassess its long-term suitability for each patient.Theropeutic ClassAdjunct anti-epileptic drugs, Benzodiazepine hypnoticsPharmacologyRivotril 0.5 mg works by reducing nerve transmission in the motor cortex, effectively suppressing the spike and wave discharges associated with absence seizures. This mechanism is thought to be linked to its ability to enhance the activity of GABA. In clinical applications, it has proven effective in improving both focal epilepsy and generalized seizures.Dosage & Administration of Rivotril 0.5 mgOral Dosage for Adults with Seizure Disorders: Begin with 1.5 mg per day, divided into three doses. Adjust by 0.5-1 mg every three days, up to a maximum of 20 mg per day. Oral Dosage for Adults with Panic Disorder: Start with 0.25 mg twice daily. After three days, increase to 1 mg per day as needed. Pediatric Patients: To minimize drowsiness, infants and children (up to 10 years or 30 kg) should take 0.01-0.03 mg/kg/day, not exceeding 0.05 mg/kg/day, split into multiple doses. Injection Dosage: Children: Administer 0.5 mg via slow IV injection or infusion.? Adults: Use 1 mg via slow IV injection or infusion, with the option to repeat if necessary (typically 1-4 mg).? Ensure a controlled IV rate of 0.25 - 0.5 mg per minute (equivalent to 0.5-1.0 ml of the solution), and do not exceed a total dose of 10 mg.Interaction of Rivotril 0.5 mgRivotril 0.5 mg does not seem to impact the pharmacokinetics of phenytoin, carbamazepine, or phenobarbital. However, its effect on the metabolism of other drugs remains unexploredContraindicationsAvoid prescribing it to patients with a history of hypersensitivity to benzodiazepines or those showing clinical or biochemical signs of significant liver disease. It can be administered to patients with open-angle glaucoma who are receiving appropriate treatment but should not be used in cases of acute narrow-angle glaucoma.Side Effects of Rivotril 0.5 mgThe most commonly observed side effects of Rivotril 0.5 mg are related to central nervous system (CNS) depression. Experience in treating seizures has revealed that drowsiness occurs in around 50% of patients, while approximately 30% experience ataxia. In some instances, these effects may diminish over time.? Additionally, behavior problems have been reported in about 25% of patients. Other potential side effects include abnormal eye movements, aphonia, coma, tremor, vertigo, confusion, depression, amnesia, hallucinations, hysteria, increased libido, insomnia, psychosis, and palpitations.Pregnancy & LactationRivotril 0.5 mg should be considered during pregnancy only when the potential benefits outweigh the risks to the fetus. It is recommended that women taking the medicine should avoid breastfeeding.Precautions & WarningsWhen administered to patients with multiple coexisting seizure disorders, this medication can potentially raise the occurrence or trigger the onset of generalized tonic-clonic seizures. In such cases, it may be necessary to supplement with suitable anticonvulsants or adjust their dosages accordingly. Combining valproic acid with Rivotril 0.5 mg may lead to the development of absence status.Overdose Effects of Rivotril 0.5 mgSymptoms: Benzodiazepines commonly result in drowsiness, ataxia, dysarthria, and nystagmus. In cases of Rivotril 0.5 mg overdose taken alone, it is rarely life-threatening but may lead to areflexia, apnea, hypotension, cardiorespiratory depression, and coma. Coma, if it occurs, typically lasts a few hours, but it may be more prolonged and cyclical in elderly patients.? Elevated seizure frequency can occur with supratherapeutic plasma concentrations. It's important to note that benzodiazepine-induced respiratory depression poses a greater risk for individuals with respiratory conditions. Additionally, benzodiazepines can amplify the effects of other central nervous system depressants, including alcohol. Treatment: Monitor the patient's vital signs and provide appropriate supportive care based on their clinical condition. Symptomatic treatment for cardiorespiratory and central nervous system effects may be necessary. To prevent further drug absorption, consider timely administration of activated charcoal within 1-2 hours. When using activated charcoal, ensure airway protection for drowsy patients.? Gastric lavage may be considered in cases of mixed ingestion but should not be routine. In cases of severe CNS depression, flumazenil, a benzodiazepine antagonist, may be an option. However, it should be administered under close monitoring due to its short half-life (approximately one hour). Patients given flumazenil will require monitoring after its effects wear off. Use flumazenil with extreme caution when other drugs that lower the seizure threshold (e.g., tricyclic antidepressants) are present. For detailed information on the correct use of flumazenil, refer to the prescribing information.Storage ConditionsKeep in a dry place away from light and heat. Keep out of the reach of children.ReconstitutionFor slow intravenous injection, it's crucial to dilute the vial's contents with 1 ml of water for injection before administering to prevent irritation of the veins. This injection solution should be prepared just before use. During IV injection, it should be administered slowly while continuously monitoring EEG, respiration, and blood pressure. When opting for intravenous infusion, Rivotril 0.5 mg (from the vial) can be diluted for infusion at a ratio of 1 vial (1 mg) to at least 85 ml of diluting media. Suitable diluting media options include sodium chloride 0.9%, sodium chloride 0.45% + glucose 2.5%, glucose 5%, or glucose 10%. These mixtures remain stable for 24 hours at room temperature.? If PVC infusion bags are used, the mixture should be infused immediately or within 4 hours. The infusion should not exceed 8 hours. Avoid preparing Rivotril 0.5 mg infusions using sodium bicarbonate solution, as it may cause solution precipitation. Intramuscular injection should be reserved for exceptional cases or when IV administration is not possible.Drug ClassesAdjunct anti-epileptic drugs, Benzodiazepine hypnoticsMode Of ActionRivotril 0.5 mg shares pharmacological properties common to benzodiazepines, encompassing anticonvulsive, sedative, muscle-relaxing, and anxiolytic effects. The central actions of benzodiazepines involve enhancing GABAergic neurotransmission at inhibitory synapses. In the presence of benzodiazepines, the GABA receptor's affinity for the neurotransmitter is boosted through positive allosteric modulation, resulting in an increased impact of released GABA on the postsynaptic transmembrane chloride ion flux. Animal studies also indicate that this pill may affect serotonin. Both animal data and electroencephalographic investigations in humans have demonstrated that Rivotril 0.5 mg rapidly suppresses various forms of paroxysmal activity, including spike and wave discharges in absence seizures (petit mal), slow spike waves, generalized spike waves, spikes with temporal or other locations, as well as irregular spikes and waves. Generalized EEG abnormalities are more consistently suppressed than focal abnormalities. Based on these findings, Rivotril 0.5 mg offers beneficial effects in both generalized and focal epilepsies.Pediatric UsesPediatric Use: In infants and young children, the use of this medication may lead to increased saliva and bronchial secretions. Therefore, it's essential to ensure clear airways. Geriatric Use: Elderly patients may experience more pronounced benzodiazepine effects compared to younger individuals, even with similar plasma benzodiazepine concentrations. This heightened sensitivity may result from age-related changes in drug-receptor interactions, post-receptor mechanisms, and organ function. Renal Impairment: Renal issues do not affect the pharmacokinetics of this medication, necessitating no dosage adjustment for patients with kidney impairment. Hepatic Impairment: In cirrhotic patients, the plasma protein binding of this medication significantly differs from that in healthy subjects, with a higher free fraction (17.1?1.0% vs. 13.9?0.2%). Although hepatic impairment's influence on Rivotril 0.5 mg pharmacokinetics hasn't been extensively studied, experience with a closely related nitrobenzodiazepine (nitrazepam) suggests that the clearance of unbound Rivotril 0.5 mg may be reduced in liver cirrhosis cases. ?Q: What is Rivotril 0.5 mg? Rivotril 0.5 mg is a clonazepam used to treat a variety of conditions, including: Epilepsy, Panic disorder, Generalized anxiety disorder, insomnia, and Muscle spasms. Q: How should I take Rivotril 0.5 mg? You should take Rivotril 0.5 mg as prescribed by your doctor. The usual dose is one or two tablets (0.5 mg or 1 mg) taken three times a day. But, it may adjust depending on your individual needs. Q: What are the side effects of Rivotril 0.5 mg? Rivotril 0.5 mg has various side effects. Some common side effects are ?drowsiness, dizziness, and confusion. Less common side effects can include memory problems, difficulty concentrating, and changes in mood. Q: Can I take Rivotril 0.5 mg if I am pregnant or breastfeeding? You shouldn?t take Rivotril 0.5 as a pregnant woman unless the benefits outweigh the risks. It is not recommended for breastfeeding women as well, as it can pass into breast milk and harm the baby. Q: Is Rivotril 0.5 mg addictive? Yes, Rivotril 0.5 mg can be addictive. You should take it exactly as prescribed by your doctor and don?t exceed the recommended dosage. If you stop taking Rivotril 0.5 mg suddenly, you may experience withdrawal symptoms, such as anxiety, insomnia, and seizures. Q: What are the long-term effects of Rivotril 0.5 mg? There isn?t any long-term effect technically. But, some people experience causes, like memory problems, difficulty concentrating, and mood changes.? Q: What should I do if I miss a dose of Rivotril 0.5 mg? If you miss a dose of Rivotril 0.5 mg, take it as soon as you remember. However, if it is close to the time for your next dose, skip the missed dose and take your next dose at the regular time. Do not take two doses at once to make up for the missed dose.Sku: 1736108117-4653
Rivotril0.5 mg
₦495.00Original price was: ₦495.00.₦455.40Current price is: ₦455.40. -
SaleBislol 5 mgBislol 5 mg is indicated in- Hypertension Angina Moderate to severe heart failureTheropeutic ClassAnti adrenergic agent (Beta blockers), Beta-adrenoceptor blocking drugs, Beta-blockersPharmacologyBisoprolol Hemifumarate is the most selective ?1 blocker. It displays highest level of affinity for the ?1 receptor than any other beta-blocker available up to now. Selectively blocks ?1 adrenergic receptor in the heart and vascular smooth muscle and reduces heart rate and cardiac output resulting in decrease of arterial hypertension. Lipid metabolism can be adversely affected by ?-blockers, in patients with non-?1 selective ?1-blocker, but Bisoprolol does not cause any change in the cholesterol fraction including the cardioprotective HDL-cholesterol, in long-term therapy.Dosage & Administration of Bislol 5 mgHypertension: The dose of Bisoprolol must be individualized to the needs of the patient. The usual starting dose is 5 mg once daily. In some patients, 2.5 mg may be an appropriate starting dose. If the antihypertensive effect of 5 mg is inadequate, the dose may be increased to 10 mg and then, if necessary, to 20 mg once daily. Angina: Usually 10 mg once daily (5 mg may be adequate in some patients) max 20 mg daily. Heart Failure: Initially 1.25 mg once daily (in the morning) for 1 week then, if well tolerated, increased to 2.5 mg once daily for 1 week, then 3.75 mg once daily for 1 week, then 5 mg once daily for 4 weeks, then- 7.5 mg once daily for 4 weeks, then 10 mg once daily maximum 10 mg daily.Interaction of Bislol 5 mgBisoprolol should not be combined with other ?-blocking agents.ContraindicationsIn patients with cardiogenic shock, overt heart failure, second or third degree A-V block, right ventricular failure secondary to pulmonary hypertension and sinus bradycardia.Side Effects of Bislol 5 mgGastro-intestinal disturbances, bradycardia, hypotension, headache, fatigue, sleep disturbances, dizziness, vertigo, thrombocytopenia, visual disturbances, alopecia may be occurred.Pregnancy & LactationThe safety of Bislol 5 mg during pregnancy has not been established.?No data is available for lactation.Precautions & WarningsMonitoring of renal, hepatic and hematopoietic function should be performed at regular intervals during long-term treatment with bisoprolol.Storage ConditionsKeep in a dry place away from light and heat. Keep out of the reach of children.Q: What is Bislol 5mg? Bislol 5 is bisoprolol, which is a beta-blocker. Beta-blockers work by slowing down the heart rate and relaxing blood vessels, which helps to lower blood pressure. Q: What is Bislol 5mg used for? People take Bislol 5mg to treat high blood pressure (hypertension). It can also be used to treat chest pain (angina) and heart failure. Q: How does Bislol 5mg work? Bislol 5mg blocks the effects of adrenaline and noradrenaline hormones that make the heart beat faster and the blood vessels constrict. Bislol 5mg blocks these horns to slow down the heart rate and relax blood vessels, which lowers blood pressure. Q: What are the side effects of Bislol 5? The common side effects of Bislol 5 are: Fatigue, Dizziness, Headache, Slow heart rate, Cold hands and feet, Difficulty breathing, Constipation, Nausea, and Diarrhea.? Q: Can I take Bislol 5mg if I am pregnant or breastfeeding? You shouldn?t take Bislol 5 during pregnancy or breastfeeding. It can cause harm to the unborn baby or nursing infant. Q: What is the dosage of Bislol 5? The dosage of Bislol 5 is different for each person. Your doctor will determine the best dosage for you based on your condition and other medications you are taking. Q: How should I take Bislol 5? You should take Bislol 5 with food to reduce the risk of stomach upset. It is usually taken once a day, but your doctor may prescribe it twice a day.Sku: 1736108113-4652
Bislol5 mg
₦8,855.00Original price was: ₦8,855.00.₦7,969.50Current price is: ₦7,969.50.₦8,855.00Original price was: ₦8,855.00.₦7,969.50Current price is: ₦7,969.50. Add to basket Quick View -
SaleAmdocal 5 mgAmdocal 5 mg is a calcium channel blocker and may be used alone or in combination with other antihypertensive and antianginal agents for the treatment of Hypertension and Coronary Artery Disease (such as Chronic Stable Angina, Vasospastic Angina and Angiographically Documented Coronary Artery Disease in patients without heart failure or an ejection fraction 1.0% are headache, fatigue, nausea, abdominal pain and somnolence.Pregnancy & LactationPregnancy Category C. There are no adequate and well-controlled studies of Amdocal 5 mg in pregnant women. Amdocal 5 mg should be used during pregnancy only if the potential benefit justifies the potential risk to the fetus. It is not known whether Amdocal 5 mg is excreted in human milk. In the absence of this information, it is recommended that nursing be discontinued while Amdocal 5 mg is administered.Precautions & WarningsSymptomatic hypotension is possible, particularly in patients with severe aortic stenosis. However, because of the gradual onset of action, acute hypotension is unlikely. Worsening angina and acute myocardial infarction can develop after starting or increasing the dose of Amdocal 5 mg, particularly in patients with severe obstructive coronary artery disease. Titrate slowly when administering calcium channel blockers to patients with severe hepatic impairment.Overdose Effects of Amdocal 5 mgIn humans, experience with intentional overdose is limited.Symptoms: Available data suggest that large overdosage could result in excessive peripheral vasodilatation and possibly reflex tachycardia. Marked and probably prolonged systemic hypotension up to and including shock with fatal outcome have been reported.Management: Clinically significant hypotension due to Amdocal 5 mg overdosage calls for active cardiovascular support including frequent monitoring of cardiac and respiratory function, elevation of extremities, and attention to circulating fluid volume and urine output.?A vasoconstrictor may be helpful in restoring vascular tone and blood pressure, provided that there is no contraindication to its use. Intravenous calcium gluconate may be beneficial in reversing the effects of calcium channel blockade. Gastric lavage may be worthwhile in some cases. In healthy volunteers the use of charcoal up to 2 hours after administration of Amdocal 5 mg 10 mg has been shown to reduce the absorption rate of Amdocal 5 mg. Since Amdocal 5 mg is highly protein-bound, dialysis is not likely to be of benefit.Storage Conditionskeep in a dry place away from light and heat. Keep out of the reach of children.Use In Special PopulationsChildren with hypertension from 6 years to 17 years of age: 2.5 mg once daily as a starting dose, up-titrated to 5 mg once daily if blood pressure goal is not achieved after 4 weeks. Doses in excess of 5 mg daily have not been studied in pediatric patients.Children under 6 years old: ?The effect of Amdocal 5 mg on blood pressure in patients less than 6 years of age is not known.Elderly: Amdocal 5 mg used at similar doses in elderly or younger patients is equally well tolerated. Normal dosage regimens are recommended in the elderly, but increase of the dosage should take place with care.Renal impairment: Changes in Amdocal 5 mg plasma concentrations are not correlated with degree of renal impairment, therefore the normal dosage is recommended. Amdocal 5 mg is not dialysable.Hepatic impairment: Dosage recommendations have not been established in patients with mild to moderate hepatic impairment; therefore dose selection should be cautions and should start at the lower end of the dosing range. The pharmacokinetics of Amdocal 5 mg have not been studied in severe hepatic impairment. Amdocal 5 mg should be initiated at the lowest dose (2.5 mg once daily) and titrated slowly in patients with severe hepatic impairment.Frequently Asked Questions Q: What is Amdocal 5mg? Amdocal 5mg is amlodipine besylate. It is a calcium channel blocker for relaxing the blood vessels and lowering blood pressure. Q: What is Amdocal 5mg used for? People take Amdocal 5mg to treat high blood pressure and chest pain or pressure (angina). Q: How does Amdocal 5mg work? Amdocal 5mg relaxes the blood vessels, which helps to lower blood pressure. It blocks the movement of calcium ions into the cells of the heart and blood vessels. Q: What are the side effects of Amdocal 5mg? The common side effects of Amdocal 5mg are - Dizziness, Headache, Fatigue, Edema (fluid retention), Flushing, Palpitations (irregular heartbeat), Rash, Nausea, Constipation, and Diarrhea.? Q: What is the dosage of Amdocal 5mg? You should take Amdocal 5mg on your doctor?s advice. Usually, the starting dose is 5mg once a day. Your doctor can increase the dose depending on your response to the medication.Sku: 1736108110-4651
Amdocal5 mg
₦4,537.50Original price was: ₦4,537.50.₦4,083.75Current price is: ₦4,083.75.₦4,537.50Original price was: ₦4,537.50.₦4,083.75Current price is: ₦4,083.75. Add to basket Quick View